Dimopoulos MA - Search Results

1

Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progression.

Dimopoulos MA, Alexanian R, Gika D, Anagnostopoulos A, Zervas C, Zomas A, Kyrtsonis MC, Anagnostopoulos N, Pangalis GA, Weber DM. Dimopoulos MA, et al. Leuk Lymphoma. 2004 Oct;45(10):2057-61. doi: 10.1080/10428190410001723287. Leuk Lymphoma. 2004. PMID: 15370250 Clinical Trial.

2

Treatment of Waldenström's macroglobulinemia with rituximab.

Dimopoulos MA, Zervas C, Zomas A, Kiamouris C, Viniou NA, Grigoraki V, Karkantaris C, Mitsouli C, Gika D, Christakis J, Anagnostopoulos N. Dimopoulos MA, et al. J Clin Oncol. 2002 May 1;20(9):2327-33. doi: 10.1200/JCO.2002.09.039. J Clin Oncol. 2002. PMID: 11981004 Clinical Trial.

3

Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.

Dimopoulos MA, Zervas C, Zomas A, Hamilos G, Gika D, Efstathiou E, Panayiotidis P, Vervessou E, Anagnostopoulos N, Christakis J. Dimopoulos MA, et al. Clin Lymphoma. 2002 Dec;3(3):163-6. doi: 10.3816/clm.2002.n.022. Clin Lymphoma. 2002. PMID: 12521393 Clinical Trial.

4

How we treat Waldenström's macroglobulinemia.

Dimopoulos MA, Merlini G, Leblond V, Anagnostopoulos A, Alexanian R. Dimopoulos MA, et al. Haematologica. 2005 Jan;90(1):117-25. Haematologica. 2005. PMID: 15642678 Review.

5

Diagnosis and management of Waldenstrom's macroglobulinemia.

Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Dimopoulos MA, et al. J Clin Oncol. 2005 Mar 1;23(7):1564-77. doi: 10.1200/JCO.2005.03.144. J Clin Oncol. 2005. PMID: 15735132 Review.

6

Predictive factors for response to rituximab in Waldenstrom's macroglobulinemia.

Dimopoulos MA, Anagnostopoulos A, Zervas C, Kyrtsonis MC, Zomas A, Bourantas C, Anagnostopoulos N, Pangalis G. Dimopoulos MA, et al. Clin Lymphoma. 2005 Mar;5(4):270-2. doi: 10.3816/clm.2005.n.014. Clin Lymphoma. 2005. PMID: 15794863 Clinical Trial.

7

Waldenström's macroglobulinemia.

Dimopoulos MA, Anagnostopoulos A. Dimopoulos MA, et al. Best Pract Res Clin Haematol. 2005;18(4):747-65. doi: 10.1016/j.beha.2005.01.028. Best Pract Res Clin Haematol. 2005. PMID: 16026748 Review.

8

Treatment of relapsed or refractory Waldenström's macroglobulinemia with bortezomib.

Dimopoulos MA, Anagnostopoulos A, Kyrtsonis MC, Castritis E, Bitsaktsis A, Pangalis GA. Dimopoulos MA, et al. Haematologica. 2005 Dec;90(12):1655-8. Haematologica. 2005. PMID: 16330439

9

Treatment of Waldenstrom's Macroglobulinemia.

Dimopoulos MA, Anagnostopoulos A. Dimopoulos MA, et al. Curr Treat Options Oncol. 2007 Apr;8(2):144-53. doi: 10.1007/s11864-007-0016-2. Curr Treat Options Oncol. 2007. PMID: 17634838 Review.

10

A revised international prognostic score system for Waldenström's macroglobulinemia.

Kastritis E, Morel P, Duhamel A, Gavriatopoulou M, Kyrtsonis MC, Durot E, Symeonidis A, Laribi K, Hatjiharissi E, Ysebaert L, Vassou A, Giannakoulas N, Merlini G, Repousis P, Varettoni M, Michalis E, Hivert B, Michail M, Katodritou E, Terpos E, Leblond V, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Leukemia. 2019 Nov;33(11):2654-2661. doi: 10.1038/s41375-019-0431-y. Epub 2019 May 22. Leukemia. 2019. PMID: 31118465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,298 results

Search Page

Filters